Regarding investor behavior amid the current market volatility, the author of today’s article observes that “A select group remains ready to take on some risk, enticed by the possibility of massive returns. Where are they looking for these opportunities? The pharmaceutical industry.” She proceeds to highlight three pharma stocks that have earned “Strong Buy” consensus ratings, offer significant upside potential – and are approaching possible catalysts. For more, CLICK HERE.
3 “Strong Buy” Pharma Stocks With Significant Upside Potential – And Catalysts Around The Corner
- by Alex Clarke
